Core Viewpoint - JY Health (605388.SH) announced a share reduction plan by several executives due to personal financial needs, intending to sell up to 474,900 shares, representing 0.079% of the total shares outstanding [1] Group 1: Share Reduction Plan - The share reduction plan involves executives Zhu Xiaoming, Luo Xiyue, Xiang Weibing, Cui Peng, and Guo Qin, who plan to reduce their holdings within three months after the announcement [1] - The total number of shares to be reduced is capped at 474,900, which is a small fraction of the company's total shares [1] Group 2: Executive Shareholdings - As of the announcement date, Zhu Xiaoming holds 613,218 shares (0.102% of total), Luo Xiyue holds 549,269 shares (0.091%), Xiang Weibing holds 276,134 shares (0.046%), Cui Peng holds 129,851 shares (0.022%), and Guo Qin holds 331,679 shares (0.055%) [1] Group 3: Company Background - JY Health was listed on the Shanghai Stock Exchange on August 18, 2020, with an initial issuance of 70 million shares at a price of 13.43 yuan per share [2] - The highest price recorded for the stock was 32.25 yuan on August 26, 2020, but it is currently trading below its initial offering price [2] Group 4: Financial Performance - The company raised a total of 940 million yuan from its initial public offering, with a net amount of 884 million yuan after deducting issuance costs [3] - For the year 2024, the company reported a revenue of 1.458 billion yuan, a year-on-year decrease of 10.77%, and a net loss attributable to shareholders of 29.12 million yuan [4] - The net cash flow from operating activities for 2024 was 32.65 million yuan, down 61.95% year-on-year [4]